The two companies that we’ve selected are:

HEALTHCARE GLOBAL ENTERPRISES LIMITED and THYROCARE TECHNOLOGIES LIMITED.

Both the companies deal with health sector.

HEALTHCARE GLOBAL ENTERPRISES LIMITED

Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in
India focused on cancer and fertility. HCG operates the largest cancer care network in India in terms of
the total number of private cancer treatment centres licensed.

Healthcare Global IPO Details:

Issue Open Mar 16, 2016 - Mar 18, 2016
Issue Type Book Built Issue IPO
Issue Size 29,800,000 Eq Shares of Rs 10 (aggregating up to Rs 649.64 Cr)
Face Value Rs 10 Per Equity Share
Issue Price Rs 205 - Rs 218 Per Equity Share
Market Lot 65 Shares
Min Order Quantity 65 Shares
Listing At BSE, NSE

Prospectus:

RISK IN RELATION TO THE FIRST OFFER

This being the first public issue of our Company, there has been no formal market for the Equity Shares.
The face value of the Equity Shares is `10 and the Floor Price is ‘x’ times the face value and the Cap Price
is ‘y’ times the face value. The Offer Price should not be taken to be indicative of the market price of the
Equity Shares after the Equity Shares are listed. No assurance can be given regarding an active or
sustained trading in the Equity Shares or regarding the price at which the Equity Shares will be traded
after listing.

GENERAL RISKS
Investments in equity and equity-related securities involve a degree of risk and investors should not
invest any funds in the Offer unless they can afford to take the risk of losing their entire investment.
Investors are advised to read the risk factors carefully before taking an investment decision in the Offer.
For taking an investment decision, investors must rely on their own examination of our Company and
the Offer, including the risks involved. The Equity Shares in the Offer have not been recommended or
approved by the Securities and Exchange Board of India (“SEBI”), nor does SEBI guarantee the accuracy
or adequacy of the contents of this Red Herring Prospectus.

ISSUER’S AND SELLING SHAREHOLDERS’ ABSOLUTE RESPONSIBILITY

Our Company, having made all reasonable inquiries, accepts responsibility for and confirms that this Red
Herring Prospectus contains all information with regard to our Company and the Offer, which is material
in the context of the Offer, that the information contained in this Red Herring Prospectus is true and
correct in all material aspects and is not misleading in any material respect, that the opinions and
intentions expressed herein are honestly held and that there are no other facts, the omission of which
makes this Red Herring Prospectus as a whole or any of such information or the expression of any such
opinions or intentions misleading in any material respect. The Other Selling Shareholders severally and
not jointly accept responsibility that this Red Herring Prospectus contains all information about them as
Other Selling Shareholders in the context of the Offer for Sale and further assume responsibility for
statements in relation to them included in this Red Herring Prospectus. Further, the Investor Selling
Shareholders severally and not jointly, accept responsibility only for statements expressly made by such
Investor Selling Shareholder in relation to itself in this Red Herring Prospectus.

LISTING
The Equity Shares offered through this Red Herring Prospectus are proposed to be listed on the BSE and
the NSE. Our Company has received an ‘in-principle’ approval from the BSE and the NSE for the listing of
the Equity Shares pursuant to letters dated September 14, 2015 and August 14, 2015, respectively. For
the purposes of the Offer, the Designated Stock Exchange shall be NSE.

THYROCARE TECHNOLOGIES LIMITED

Incorporated in 2000, Thyrocare Technologies Ltd is one of the leading pan-India diagnostic chains and
conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and
management of disorders and diseases.

Thyrocare Technologies IPO Details:

Issue Open Apr 27, 2016 - Apr 29, 2016
Issue Type Book Built Issue IPO
Issue Size 10,744,708 Eq Shares of Rs 10 (aggregating up to Rs 479.21 Cr)
Offer for Sale 10,744,708 Eq Shares of Rs 10
Face Value Rs 10 Per Equity Share
Issue Price Rs 420 - Rs 446 Per Equity Share
Market Lot 33 Shares
Min Order Quantity 33 Shares
Listing At BSE, NSE

Prospectus:

RISKS IN RELATION TO THE FIRST OFFER

This being the first public offer of our Company, there has been no formal market for the Equity Shares
of our Company. The face value of the Equity Shares is ₹ 10 per Equity Share. The Floor Price is ‘x’ times
the face value and the Cap Price is ‘y’ times the face value. The Offer Price should not be taken to be
indicative of the market price of the Equity Shares after the Equity Shares are listed. No assurance can
be given regarding an active or sustained trading in the Equity Shares or regarding the price at which the
Equity Shares will be traded after listing.

GENERAL RISKS
Investments in equity and equity-related securities involve a degree of risk and investors should not
invest any funds in this Offer unless they can afford to take the risk of losing their investment. Investors
are advised to read the risk factors carefully before taking an investment decision in this Offer. For
taking an investment decision, investors must rely on their own examination of our Company and the
Offer, including the risks involved. The Equity Shares offered in the Offer have not been recommended
or approved by SEBI, nor does SEBI guarantee the accuracy or adequacy of the contents of this Red
Herring Prospectus.

COMPANY’S AND SELLING SHAREHOLDERS’ ABSOLUTE RESPONSIBILITY

Our Company, having made all reasonable inquiries, accepts responsibility for and confirms that this Red
Herring Prospectus contains all information with regard to our Company and the Offer, which is material
in the context of the Offer, that the information contained in this Red Herring Prospectus is true and
correct in all material aspects and is not misleading in any material respect, that the opinions and
intentions expressed herein are honestly held and that there are no other facts, the omission of which
makes this Red Herring Prospectus as a whole or any of such information or the expression of any such
opinions or intentions misleading in any material respect. Further, each Selling Shareholder, severally
and not jointly, accepts responsibility that this Red Herring Prospectus contains all information about
him or it as a Selling Shareholder in the context of the Offer and assumes responsibility only for
statements in relation to such Selling Shareholder included in this Red Herring Prospectus and the
respective proportion of the Equity Shares offered by him or it in the Offer and such statements are
true, complete and correct in all material respects and are not misleading in any material respect .

LISTING
The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on the BSE and
NSE. Our Company has received an ‘in-principle’ approval from each of the BSE and the NSE for the
listing of the Equity Shares pursuant to the letters dated January 14, 2016 and January 18, 2016,
respectively. For the purposes of the Offer, the Designated Stock Exchange shall be NSE.
A copy of the Red Herring Prospectus has been delivered to the Registrar of Companies and a copy of
the Prospectus shall be delivered for registration to the Registrar of Companies in accordance with
Section 26(4) of the Companies Act, 2013.